INROBICS Social Robotics

INROBICS operates at the intersection of artificial intelligence, robotics, and digital rehabilitation. Its stated focus is supporting people with functional or neurological limitations through personalized physical and cognitive training, with applications spanning rehabilitation centers, hospitals, special education, care settings, and the home. The product range covers both delivery and measurement: Inrobics Rehab Clinic uses a physical social robot, therapeutic games, and sensors; Rehab Virtual supports remote sessions through a virtual social robot; and Inrobics Analytics captures performance data to help track progress. ALMA Software provides the interaction layer across these experiences. The company also describes Inrobics Rehab as a Class I medical device with CE marking under EU Regulation 2017/745. That combination of robotics, remote access, and session analytics is a concrete point of distinction from a rehabilitation offering limited to either in-person equipment or standalone digital exercises. The company’s profile does not identify comparable competitors by name, so a direct competitor ranking is not supportable here. Its category placement is AI and robotics, and the reported 11–50 employee range suggests a smaller-scale company relative to established medical-device and healthcare technology groups.

Founded in 2020, INROBICS has developed a portfolio that spans clinic-based rehabilitation, remote therapy, performance analytics, and the ALMA software that powers social-robot interactions. Its clearest disclosed financing inflection point is the Aug 2, 2022 pre-seed round of €350,000 ($355,482), led by Grow Venture Partners with Capital Cell participating. Product breadth indicates a strategy of serving multiple care environments rather than relying exclusively on a physical robot: clinic systems, virtual home sessions, and analytics address different parts of rehabilitation delivery. Website information also describes deployment through physical robots, virtual-reality headsets, Android devices, and other screens. These facts point to a shift from a robotics-centered concept toward a multi-platform rehabilitation system, but the available milestones do not establish the pace of adoption, revenue growth, or later-stage financing.